| Authors: |
Chevalier B; Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, F-59000 Lille, France; University of Lille, F-59000 Lille, France. Electronic address: benjamin.chevalier@chu-lille.fr., Jannin A; Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, F-59000 Lille, France; University of Lille, F-59000 Lille, France; University of Lille, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France., Espiard S; Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, F-59000 Lille, France; University of Lille, F-59000 Lille, France; INSERM U1190, European Genomic Institute for Diabetes, F-59000 Lille, France., Merlen E; Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, F-59000 Lille, France., Beron A; Department of Nuclear Medicine, Lille University Hospital, F-59000 Lille, France., Lion G; Department of Nuclear Medicine, Lille University Hospital, F-59000 Lille, France., Vantyghem MC; Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, F-59000 Lille, France; University of Lille, F-59000 Lille, France; INSERM U1190, European Genomic Institute for Diabetes, F-59000 Lille, France., Huglo D; University of Lille, F-59000 Lille, France; Department of Nuclear Medicine, Lille University Hospital, F-59000 Lille, France; INSERM U1189 OncoTHAI, avenue Oscar Lambret, 59000 Lille, France., Cortet-Rudelli C; Department of Endocrinology, Diabetology and Metabolism, Lille University Hospital, F-59000 Lille, France., Baillet C; Department of Nuclear Medicine, Lille University Hospital, F-59000 Lille, France. |
